Two patients with concomitant bullous pemphigoid and psoriasis successfully treated by IL-23 inhibition

被引:2
|
作者
Cole, Connor [1 ,4 ]
Amber, Kyle T. [2 ,3 ]
机构
[1] Rush Med Coll, Chicago, IL USA
[2] Rush Univ, Dept Dermatol, Med Ctr, Chicago, IL USA
[3] Rush Univ, Dept Internal Med, Med Ctr, Chicago, IL USA
[4] Rush Med Coll, 1826 Erie St APT BF, Chicago, IL 60622 USA
关键词
USTEKINUMAB;
D O I
10.1111/jdv.19317
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:E1339 / E1340
页数:2
相关论文
共 50 条
  • [41] Interleukin (IL)-36γ induces IL-23 production and angiogenesis in psoriasis
    Bridgewood, C.
    Fearnley, G.
    Keszegpal, A.
    Laws, P.
    Ponnambalam, S.
    Graham, A.
    Stacey, M.
    Wittmann, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E291 - E291
  • [42] Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
    Ghoreschi, Kamran
    Balato, Anna
    Enerback, Charlotta
    Sabat, Robert
    LANCET, 2021, 397 (10275): : 754 - 766
  • [43] Adalimumab-induced paradoxical psoriasis treated with biologics targeting the IL-17/IL-23 axis in patients with hidradenitis suppurativa
    Tsiogka, Aikaterini
    Liakou, Aikaterini I.
    Agiasofitou, Efthimia
    Gregoriou, Stamatis
    Stratigos, Alexander
    Rigopoulos, Dimitrios
    Kontochristopoulos, Georgios
    DERMATOLOGY, 2023, 239 (06) : 937 - 941
  • [44] IL-23 inhibition for the treatment of psoriatic arthritis
    Mohanakrishnan, Raagav
    Beier, Secia
    Deodhar, Atul
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (01) : 59 - 65
  • [45] IL-23 inhibition for chronic inflammatory disease
    Jairath, Vipul
    Felquer, Maria Laura Acosta
    Cho, Raymond Jaihyun
    LANCET, 2024, 404 (10463): : 1679 - 1692
  • [46] A single-cell atlas of IL-23 inhibition in cutaneous psoriasis distinguishes clinical response
    Wu, David
    Hailer, Ashley A.
    Wang, Sijia
    Yuan, Michelle
    Chan, Jamie
    El Kurdi, Abdullah
    Han, David
    Ali, Hira
    D'Angio, Blaize
    Mayer, Aaron
    Rahim, Maha
    Kondo, Ayano
    Klufas, Daniel M.
    Kim, Esther A.
    Shain, A. Hunter
    Choi, Jaehyuk
    Bhutani, Tina
    Simpson, Gregory L.
    Grekin, Roy C.
    Ricardo-Gonzalez, Roberto R.
    Purdom, Elizabeth
    North, Jeffrey P.
    Cheng, Jeffrey B.
    Cho, Raymond J.
    SCIENCE IMMUNOLOGY, 2024, 9 (91)
  • [47] Evaluation of interleukin-23 receptor (IL-23R) gene polymorphisms and serum IL-23 levels in patients with psoriasis
    Filiz, Basak
    Yildirim, Mehmet
    Hekimler Ozturk, Kuyas
    Sirin, Fevziye Burcu
    Celik, Seda
    Erturan, Ijlal
    Korkmaz, Selma
    Orhan, Hikmet
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2019, 49 (05) : 1386 - 1394
  • [48] BULLOUS PEMPHIGOID IN LATE CHILDHOOD SUCCESSFULLY TREATED WITH MYCOPHENOLATE MOFETIL AS AN ADJUVANT THERAPY
    Fox, John C.
    Kenkare, Sonya
    Petronic-Rosic, Vesna
    Soltani, Keyoumars
    Sethi, Aisha
    PEDIATRIC DERMATOLOGY, 2010, 27 (05) : 537 - 539
  • [49] Refractory Bullous Pemphigoid Successfully Treated with Reslizumab: A Possible Novel Therapeutic Modality
    Kwon, Hyeok-Jin
    Kim, Ki-Ho
    Yoon, Jung-Ho
    ANNALS OF DERMATOLOGY, 2023, 35 : S103 - S106
  • [50] Infantile bullous pemphigoid successfully treated with i.v. immunoglobulin and cyclosporin
    Okada, Karin
    Kakeda, Masato
    Yamamoto, Shinya
    Yokoyama, Tomoya
    Habe, Koji
    Nakato, Daisuke
    Hirayama, Masahiro
    Mizutani, Hitoshi
    Yamanaka, Keiichi
    JOURNAL OF DERMATOLOGY, 2019, 46 (06): : E213 - E214